Liver cancer ranks third among all cancer deaths in Bangladesh.Chronic hepatitis B and C virus infections are blamed as the main reasons for liver cancer in Bangladesh.Most of them are diagnosed in the advanced stage, when surgery is no longer possible.The procedure, transarterial chemoembolization (TACE), had been implemented in Bangladesh for the first time in Bangladesh. A group of doctors in Bangladesh have “successfully” performed the new procedure for treating liver cancer. This is the best best option for those whose cancerous tumour in the liver cannot be removed surgically. This marks a new era in the arena of interventional hepatology in Bangladesh. Surgery is not possible for many liver cancer patients due to the size and location of the tumour, particularly when it grows into the blood vessels. This is a minimally invasive image-guided treatment in which chemotherapy is delivered directly to the tumour through blood vessels. Our (Bangladeshi) patients will now have access to this unique and advanced management of liver cancer at less than half the price of TACE in India. This procedure will shortly be available in government hospitals as well, since the doctors in the team work in different government hospitals